Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E968 SCHEMBL30287920 | 1.00 | — | — | |
| E968 SCHEMBL13727065 | 1.00 | LMNA (0.67) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| E968 SCHEMBL36228 | 1.00 | — | — | |
| E968 SCHEMBL10427336 | 1.00 | — | — | |
| E968 SCHEMBL121807 | 1.00 | — | — | |
| E968 SCHEMBL2723809 | 1.00 | LMNA (0.67) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| E968 SCHEMBL17062 | 1.00 | — | — | |
| E968 SCHEMBL6729753 | 1.00 | — | — | |
| E968 SCHEMBL17766 | 1.00 | — | — | |
| E968 SCHEMBL9566824 | 1.00 | LMNA (0.67) | LMNAL3MBTL1TDP1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11929171-B2 | Methods for evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease and applications thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-03-12 | — | — | US | disclosed |
| US-20200227166-A1 | Methods for Evaluation and Treatment of Glycemic Dysregulation and Atherosclerotic Cardiovascular Disease and Applications Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2020-07-16 | — | — | US | disclosed |
| EP-3313994-A1 | CARBON-NEUTRAL AND CARBON-POSITIVE PHOTORESPIRATION BYPASS ROUTES SUPPORTING HIGHER PHOTOSYNTHETIC RATE AND YIELD | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016207219-A1 | CARBON-NEUTRAL AND CARBON-POSITIVE PHOTORESPIRATION BYPASS ROUTES SUPPORTING HIGHER PHOTOSYNTHETIC RATE AND YIELD | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-12-29 | — | — | WO | disclosed |
| EP-2582231-A1 | TOPICAL GERMICIDAL COMPOSITIONS | Reckitt Benckiser LLC (US) | 2013-04-24 | — | — | EP | disclosed |
| EP-1695088-B1 | METHOD FOR ANALYSING METABOLITES | MAX PLANCK GESELLSCHAFT (DE) | 2012-04-18 | — | — | EP | disclosed |
| WO-2011158026-A1 | TOPICAL GERMICIDAL COMPOSITIONS | RECKITT BENCKISER LLC (US) | 2011-12-22 | — | — | WO | disclosed |